China Biotech Services Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-252.00
-134.00
867.00
180.00
202.00
-108.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-50.00
491.00
-433.00
-225.00
172.00
22.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-157.00
189.00
479.00
37.00
416.00
-31.00
Cash Flow from Investing Activities
4.00
-51.00
-127.00
-7.00
-124.00
-98.00
Cash Flow from Financing Activities
71.00
-149.00
-278.00
-263.00
47.00
22.00
Net Cash Inflow / Outflow
-83.00
-14.00
70.00
-233.00
339.00
-108.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
-2.00
-2.00
0.00
0.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of China Biotech Services Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-252.797
84.6867401279807
-336.00
-398.51%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-50.93
42.7388097659287
-92.00
-219.17%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-157.291
148.677497439665
-305.00
-205.79%
Cash Flow from Investing Activities
4.107
102.438459024895
-98.00
-95.99%
Cash Flow from Financing Activities
71.302
-7.29801588527767
78.00
1077.01%
Net Cash Inflow / Outflow
-83.206
226.43425467229
-309.00
-136.75%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.324
-17.3836859069919
16.00
92.38%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -183.18% vs -60.53% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-157.29
189.10
-183.18%






